InsidersTradesSigma
제테마 Stock: price and management transactions · South Korea · DART (FSS)
Follow the 제테마 share price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares are listed on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 제테마 has published 121 public disclosures. Market capitalisation: €206.1bn. The latest transaction was filed on 3 July 2026 (Other). Among the most active insiders: 박종우. Every trade is openly available.
121
Insider Decl.
0
Thresholds
€277,791
12 ops.
Buy Volume
€4m
6 ops.
Sell Volume
23Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 22,996 of 26,282 companies
24.4
score / 100
Value22
Quality27
FCF yld-2.9%
Earn yld-4.0%
EV/EBITDA24.6x
ROE-8.2%
Gross mgn48%
Net mgn-8.6%
Debt/EBITDA10.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 3 July 2026
Declarations121 total
25 of 121 declarations
About 제테마
제테마 is a company operating in the health and pharmaceutical sector, listed on the XKRX market. It specializes in the development and commercialization of pharmaceutical products.